These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26950147)
1. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals. Neves AR; Martins S; Segundo MA; Reis S Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147 [TBL] [Abstract][Full Text] [Related]
2. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Neves AR; Lúcio M; Martins S; Lima JL; Reis S Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193 [TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
4. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
5. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability. Talegaonkar S; Bhattacharyya A AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893 [TBL] [Abstract][Full Text] [Related]
6. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes. Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412 [TBL] [Abstract][Full Text] [Related]
8. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies. Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794 [TBL] [Abstract][Full Text] [Related]
9. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
10. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Chen CC; Tsai TH; Huang ZR; Fang JY Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469 [TBL] [Abstract][Full Text] [Related]
11. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies. Patel M; Mundada V; Sawant K Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):144-153. PubMed ID: 30669881 [TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
13. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics. Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951 [TBL] [Abstract][Full Text] [Related]
14. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Ramalingam P; Ko YT Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233 [TBL] [Abstract][Full Text] [Related]
15. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Siu FY; Ye S; Lin H; Li S Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy. Daré RG; Costa A; Nakamura CV; Truiti MCT; Ximenes VF; Lautenschlager SOS; Sarmento B Int J Pharm; 2020 May; 582():119336. PubMed ID: 32304728 [TBL] [Abstract][Full Text] [Related]
17. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764 [TBL] [Abstract][Full Text] [Related]